Changing Agendas on Sleep, Treatment and Learning in Epilepsy
NCT04610879 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2020-11-02
Summary
Rolandic epilepsy (RE) is the most common type of epilepsy. Children with RE have seizures and can often find that their learning, sleep, behaviour, self-esteem and mood are affected.
As part of standard NHS care, children diagnosed with RE may be treated with standard anti-epileptic medicines, like carbamazepine, or no medicine at all. The medicines used to treat epilepsy often slow down a child's thinking and learning. In the past, doctors believed this was an acceptable price to pay to reduce seizures. However, with RE, where the seizures usually stop in teenage years, investigators do not know if it is better to treat these children with medicines or not, especially if the medicines might have a negative effect on their learning.
A newer medicine called levetiracetam has also been found to work in children with RE and has shown less problems with thinking and learning in adults. However, it is still no known if this is also the case for children and it has not been proven which of the three options (carbamazepine, levetiracetam or no treatment) would be best for RE patients. The CASTLE study aims to find this out.
In addition, it has been found that seizures often happen when a child has had poor sleep and they often come at night or early in the morning. It has been shown that sleep can be improved through practice without the need of medicines. There are established guidelines to help toddlers go to sleep, but nothing available that helps young people with epilepsy and their parents improve their sleep quality. In the CASTLE study, a sleep training plan has been developed for children with epilepsy and the trial aims to find out whether following this sleep training plan results in less seizures than using no sleep training at all.
Conditions
- Rolandic Epilepsy
Interventions
- DRUG
-
Carbamazepine
Treatment will be procured, prescribed and issued as per routine NHS practice. Generics can be prescribed.
- DRUG
-
Treatment will be procured, prescribed and issued as per routine NHS practice. Generics can be prescribed.
- BEHAVIORAL
-
Parent based sleep (PBS) intervention
The PBS intervention is an e-learning package for parents/primary carers and children with epilepsy. The PBS intervention offers parents education about normal sleep, advice about sleep-promoting practices and targeted strategies parents can employ to help their children to ''learn'' an appropriate set of sleep behaviours/habits and/or to unlearn inappropriate sleep behaviours.
Sponsors & Collaborators
-
King's College Hospital NHS Trust
collaborator OTHER -
University of Liverpool
collaborator OTHER -
Bangor University
collaborator OTHER -
Edge Hill University
collaborator OTHER -
Oxford Brookes University
collaborator OTHER - lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 5 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-02
- Primary Completion
- 2020-09-23
- Completion
- 2020-09-23
Countries
- United Kingdom
Study Locations
More Related Trials
-
Pharmacological Management of Seizures Post Traumatic Brain Injury
NCT04573803 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
NCT00242606 ·Status: COMPLETED ·Phase: PHASE3
-
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
NCT00105040 ·Status: COMPLETED ·Phase: PHASE2
-
Levetiracetam Treatment of Neonatal Seizures
NCT02550028 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
HEAD-Study Optimizing the Treatment of Children With BECTS
NCT00471744 ·Status: TERMINATED ·Phase: PHASE3
-
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
NCT01521130 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
NCT00152516 ·Status: COMPLETED ·Phase: PHASE3
-
A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
NCT00175890 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam for Benign Rolandic Epilepsy
NCT00181116 ·Status: COMPLETED ·Phase: PHASE4
-
The "New" Place of LEVETIRACETAM in the Management of Status Epilepticus in Children
NCT06498362 ·Status: RECRUITING
-
Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus
NCT00603135 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
NCT01720667 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus
NCT02920060 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures
NCT00615615 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
NCT01063764 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
NCT00361010 ·Status: COMPLETED ·Phase: NA
-
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691 ·Status: RECRUITING ·Phase: PHASE4
-
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
NCT05610085 ·Status: RECRUITING ·Phase: PHASE2
-
Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
NCT00150748 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
NCT00629889 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Effects of Treatment of Interictal Discharges
NCT00916149 ·Status: COMPLETED ·Phase: NA
-
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
NCT00247364 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study
NCT02208492 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
NCT03340064 ·Status: COMPLETED ·Phase: PHASE3
-
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
NCT02726867 ·Status: WITHDRAWN ·Phase: PHASE3